Abstract Context The European Association of Urology (EAU) Guidelines Panel on Upper
Urinary Tract Urothelial Carcinoma (UTUC) has prepared updated guidelines to aid …

Context To improve the prognosis of upper tract urothelial carcinoma (UTUC), clinicians
have used neoadjuvant chemotherapy (NAC) or adjuvant chemotherapy (AC) before or after …

Background Urothelial carcinomas of the upper urinary tract (UTUCs) are rare, with poorer
stage-for-stage prognosis than urothelial carcinomas of the urinary bladder. No international …

Abstract Context The European Association of Urology (EAU) guidelines panel on upper
urinary tract urothelial cell carcinoma (UTUC) has prepared updated guidelines to aid …

Purpose Given that randomized trials exploring adjuvant chemotherapy for bladder cancer
have been underpowered and/or terminated prematurely, yielding inconsistent results and …

Purpose There is limited evidence to support the use of adjuvant chemotherapy (AC) after
radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Against this …

Context The oncological efficacy of routine lymphadenectomy (lymph node dissection [LND])
at the time of radical nephroureterectomy (RNU) remains controversial. Objective To …

Purpose: Data supporting neoadjuvant chemotherapy of high grade upper tract urothelial
carcinoma are scant. In this multi-institution, prospective, phase II trial we investigated …

Introduction Upper tract urothelial carcinoma (UTUC) is a relatively uncommon urologic
malignancy for which there has not been significant improvement in survival over the past …

Background Neoadjuvant chemotherapy (NAC) use for patients with locally advanced upper
tract urothelial carcinoma (UTUC) is debatable. Objective To investigate the efficacy and …